From: Breast cancer in togolese women: immunohistochemistry subtypes
Variables | Luminal A N = 36 n (%) | Luminal B N = 28 n (%) | Triple negative N = 44 n (%) | HER enriched N = 9 n (%) | P value |
---|---|---|---|---|---|
Mean age (years) | 54.14 ± 12.7 | 51.07 ± 13.19 | 52.16 ± 12.44 | 46.33 ± 6.30 | 0.377 |
Age group (years) | |||||
< 40 | 1 (2.8) | 5 (17.9) | 8 (18.1) | 1 (11.1) | 0.172 |
[40–50] | 14 (38.9) | 6 (21.4) | 12 (27.3) | 6 (66.7) | |
[50–60] | 12 (33.3) | 10 (35.7) | 12 (27.3) | 2 (22.2) | |
≥ 60 | 9 (25) | 7 (25) | 12 (27.3) | 0 | |
Menopausal status | |||||
Premenopausal | 7 (19.4) | 10 (35.7) | 13 (29.5) | 5 (44.4) | 0.163 |
Postmenopausal | 29 (80.6) | 18 (64.3) | 31 (70.5) | 4 (55.6) | |
Stage | |||||
I | 3 (8.3) | 0 | 0 | 0 | 0.025 |
II | 15 (41.7) | 12 (42.9) | 18 (40.9) | 0 | |
III | 15 (41.7) | 7 (25) | 15 (34.1) | 5 (55.6) | |
IV | 3 (8.3) | 9 (32.1) | 11 (25) | 4 (44.4) | |
Grade | |||||
1 | 4 (11.1) | 0 | 3 (6.8) | 0 | < 0.0001 |
2 | 29 (80.6) | 7 (25) | 17 (38.6) | 7 (77.8) | |
3 | 3 (8.3) | 21 (75) | 24 (54.6) | 2 (22.2) | |
Tumor size | |||||
T1 | 6 (16.7) | 1 (3.6) | 3 (6.8) | 0 | 0.078 |
T2 | 16 (44.4) | 13 (46.4) | 17 (38.7) | 0 | |
T3 | 9 (25) | 7 (25) | 10 (22.7) | 0 | |
T4 | 5 (13.9) | 7 (25) | 14 (31.8) | 9 (100) |